Committee for Orphan Medicinal Products (COMP)
GPTKB entity
Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Committee
|
| gptkbp:advises |
gptkb:European_Commission
|
| gptkbp:advocatesFor |
increased funding for orphan drug research
|
| gptkbp:affiliation |
gptkb:European_Medicines_Agency
|
| gptkbp:aimsTo |
facilitate development of treatments for rare diseases
regulatory processes for orphan drugs |
| gptkbp:analyzes |
clinical trials for orphan drugs
market needs for orphan drugs |
| gptkbp:assists |
orphan_drug_designation_applications
|
| gptkbp:collaborates_with |
other regulatory bodies
|
| gptkbp:collaborations |
industry and academia
|
| gptkbp:composedOf |
experts in various fields
|
| gptkbp:contributedTo |
public health policy
|
| gptkbp:contribution |
orphan_drug_guidelines.
|
| gptkbp:develops |
strategies for orphan drug approval
|
| gptkbp:established |
2000
|
| gptkbp:evaluates |
market authorization applications for orphan drugs
scientific data on orphan drugs |
| gptkbp:facilitates |
stakeholder engagement in orphan drug policy
|
| gptkbp:feedback |
orphan_drug_development_plans
|
| https://www.w3.org/2000/01/rdf-schema#label |
Committee for Orphan Medicinal Products (COMP)
|
| gptkbp:impact |
orphan_drug_policies
|
| gptkbp:influences |
gptkb:EU_orphan_drug_legislation
|
| gptkbp:is_a_platform_for |
discussion on orphan drug issues
|
| gptkbp:issueFeePaid |
orphan_drug_incentives
|
| gptkbp:location |
Amsterdam,_Netherlands
|
| gptkbp:meets |
monthly
|
| gptkbp:monitors |
orphan_drug_market_trends
|
| gptkbp:participatesIn |
international conferences on rare diseases
|
| gptkbp:promotes |
rare diseases
patient access to orphan drugs |
| gptkbp:provides |
patient needs for orphan drugs
orphan_drug_designation_process orphan_drug_development orphan_drug_pricing orphan_medicinal_products |
| gptkbp:provides_access_to |
orphan_drugs_in_the_EU
|
| gptkbp:providesInformationOn |
EU_health_programs
|
| gptkbp:providesTrainingFor |
orphan_drug_regulations
|
| gptkbp:purpose |
Evaluate applications for orphan designation
|
| gptkbp:reportsTo |
gptkb:European_Medicines_Agency
|
| gptkbp:reviews |
rare diseases
orphan_drug_applications |
| gptkbp:suitableFor |
clinical trial design for orphan drugs
|
| gptkbp:supports |
research on rare diseases
|
| gptkbp:works_with |
patient advocacy groups
|